Carlyle Group Inc. - Q2 2021 holdings

$14.8 Billion is the total value of Carlyle Group Inc.'s 11 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 16.7% .

 Value Shares↓ Weighting
ZI SellZoomInfo Technologies Inc$4,606,375,000
+5.5%
88,295,467
-1.1%
31.17%
-5.7%
ATC  Atotech Ltd$3,923,264,000
+26.1%
153,672,7030.0%26.55%
+12.7%
OCDX  Ortho Clinical Diagnostics H$3,070,322,000
+11.0%
143,406,0000.0%20.78%
-0.8%
PPD  PPD Inc$2,568,261,000
+21.8%
55,722,7330.0%17.38%
+8.9%
ONEM  1Life Healthcare Inc$450,035,000
-15.4%
13,612,6810.0%3.04%
-24.3%
VTRU  Vitru Ltd$107,439,000
+15.8%
6,246,4710.0%0.73%
+3.6%
TALO SellTalos Energy Inc$36,368,000
-39.1%
2,325,337
-53.1%
0.25%
-45.6%
ONE  Onesmart Intl Ed Group Ltdsponsored ads$9,668,000
-54.1%
7,860,0000.0%0.06%
-59.1%
SMHI  Seacor Marine Hldgs Inc$5,063,000
-17.3%
1,147,9890.0%0.03%
-26.1%
SPNT  SiriusPoint Ltd$1,303,000
-1.0%
129,4080.0%0.01%
-10.0%
DOC ExitPhysicians Rlty Tr$0-587,838
-100.0%
-0.08%
LBRT ExitLiberty Oilfield Svcs Inc$0-12,299,996
-100.0%
-1.05%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
eFFECTOR Therapeutics, Inc.August 18, 20234,829,8917.8%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
QuidelOrtho CorpJune 06, 202212,460,18318.6%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
ARS2024-04-18
DEF 14A2024-04-18
DEFA14A2024-04-18
8-K2024-04-03
PRE 14A2024-04-03
42024-04-02
SC 13G2024-03-29
8-K2024-03-27
42024-03-05
SC 13D/A2024-03-05

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings